Myriad Genetics Inc MYGN

Healthcare Biotechnology

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.

NDAQ:MYGN - Post by User

Myriad Genetics Inc

Bullboard Posts

Post by SCCNewsServiceson Apr 17, 2000 11:56am

446 Views

Post# 1798133

Genomics Execs Aren’t Worried

Ignore the bears, genomics bulls say. Advancements in medicine are coming and companies that understand genes are the ones that will make them. To read the full story click on: https://www.smallcapcenter.com/story.asp?&mb=1storytype=sccnews&component=story.asp&storyid=6641

Bullboard Posts

Morning Market Outlook for June 17, 2024